Mesenchymal stem cells are sensitive to bleomycin treatment

Mesenchymal stem cells (MSCs) have been shown to attenuate pulmonary damage induced by bleomycin-based anticancer treatments, but the influence of bleomycin on the stem cells themselves remains largely unknown. Here, we demonstrate that human bone marrow-derived MSCs are relatively sensitive to bleo...

Full description

Bibliographic Details
Main Authors: Nicolay, Nils H., Rühle, Alexander, Perez, Ramon Lopez, Trinh, Thuy, Sisombath, Sonevisay, Weber, Klaus-Josef, Ho, Anthony D., Debus, Jürgen, Saffrich, Rainer, Huber, Peter E.
Format: Online
Language:English
Published: Nature Publishing Group 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877675/